Results 91 to 100 of about 29,629 (128)

Dual Inhibitors of KRASG12D and HSP90 Are Effective against KRASG12D Inhibitor Resistance. [PDF]

Mol Cancer Ther
Pulido I, Gunder LC, Ying C, Wang Y, Dai Y, Yang Z, Rahnama A, Li J, Sun Y, Liu C, Zhou H, Wang G, Foley KP, Abdelhady K, Massad MG, Prince TL, Papautsky I, Ying W, Shimamura T.   +18 more
europepmc   +1 more source

Proto-Oncogene HRAS Transcript Level and Overall Survival in Stages II and III Colorectal Cancer. [PDF]

Cancer Med
Kim D, Sharif S, Garay JAR, Bhakta AS, Boland PM, Cavnar MJ, Churchman ML, Hatoum H, Huang LC, Kim J, Kim R, Lentz RW, Mukherjee S, O'Donnell MT, Quartey B, Reilley MJ, Rounbehler RJ, Salhia B, Schneider BP, Chan CH.   +19 more
europepmc   +1 more source

A novel anticancer natural product SP09 selectively targets KRAS-mutant NSCLC through LKB1/AMPK/mTOR modulation: implications for novel therapeutic development. [PDF]

Anticancer Drugs
Yue P, Hon C, Zhao X, Ali F, Sun J, Kou J.   +5 more
europepmc   +1 more source

Clinical Significance and Potential Molecular Mechanisms of Angiotensin-Converting Enzyme 2 in Colorectal Cancer. [PDF]

World J Oncol
Zeng DT, Yang L, Wen JY, Wu KJ, Chen GQ, Li ZY, Ling JW, Huang BB, Xie YY, Dong YY, Fang YY, Wei DM, Chen G, Shi L, Huang WJ.   +14 more
europepmc   +1 more source

Cotargeting DNA topoisomerase II enhances efficacy of RAS-targeted therapy in KRAS-mutant cancer models. [PDF]

J Clin Invest
Xu R, Wang D, Ma G, Yuan X, Chu Q, Fan S, Zhang R, Du P, Jia S, Leal TA, Ramalingam SS, Chen Z, Sun SY.   +12 more
europepmc   +1 more source

Liquid Biopsy as a Means of Assessing Prognosis and Identifying Novel Risk Factors in Multiple Myeloma. [PDF]

Int J Mol Sci
Soloveva M, Solovev M, Yakutik I, Biderman B, Nikulina E, Risinskaya N, Obukhova T, Gladysheva M, Kovrigina A, Chabaeva Y, Kulikov S, Sudarikov A, Mendeleeva L.   +12 more
europepmc   +1 more source

Kras and ciliary gene mutations cooperatively lead to pancreatic tumorigenesis only when induced during embryogenesis. [PDF]

Sci Rep
Fages A, Rajput M, Sempoux C, Jacquemin P.   +3 more
europepmc   +1 more source

Gamma-glutamyl transferase as a redox-gatekeeper biomarker for pancreatic cystic neoplasms: A concise roadmap from epidemiology to bedside. [PDF]

World J Gastroenterol
Qiu MQ, Chen MM, Yang WJ, Qiu WS.
europepmc   +1 more source

EC359 Enhances Trametinib Efficacy in <i>Ras</i>/<i>Raf</i>-Driven Ovarian Cancer by Suppressing LIFR Signaling. [PDF]

Biomolecules
Arnold WC, Panneerdoss DM, Subramani B, Mahajan M, Ebrahimi B, Ramirez P, Santhamma B, Viswanadhapalli S, Kost ER, Chen Y, Lai Z, Nair HB, Vadlamudi RK, Lyons YA.   +13 more
europepmc   +1 more source

Switching It up with New KRAS Inhibitors. [PDF]

J Med Chem
Waterson AG.
europepmc   +1 more source